ADBiotech Co

ADBiotech Co Capital Intensity

The Capital Intensity Ratio of ADBiotech Co (179530.KQ) as of Nov 22, 2026 is 375.34 %. In the previous year, Capital Intensity Ratio was 207.20 % — a change of 81.15% (higher).

Capital Intensity

375.34 %

YoY

81.15%

Last updated:

Capital Intensity Ratio of ADBiotech Co is 2025 375.34 % . Capital Intensity Ratio of ADBiotech Co was 2024 207.20 % . It decreases by 81.15% higher compared to the previous year.

The ADBiotech Co Capital Intensity history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Capital Intensity
Date
Capital Intensity
Jan 1, 2018
130.49 KRW
Jan 1, 2019
118.14 KRW
Jan 1, 2020
191.95 KRW
Jan 1, 2021
177.02 KRW
Jan 1, 2022
291.75 KRW
Jan 1, 2023
268.27 KRW
Jan 1, 2024
207.20 KRW
Jan 1, 2025
375.34 KRW
The ADBiotech Co Capital Intensity history
YEARCapital IntensityYoY
375.34 %+81.15%
207.20 %-22.76%
268.27 %-8.05%
291.75 %+64.82%
177.02 %-7.78%
191.95 %+62.47%
118.14 %-9.46%
130.49 %-14.00%
151.73 %-25.14%
202.67 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

ADBiotech Co Stock analysis

What does ADBiotech Co do? ADbiotech Co., Ltd. generates revenue by manufacturing and selling chemical products across two distinct business segments. The Veterinary Medicine segment focuses on the production of antibiotics, anticoccidial agents, antimicrobial agents, nervous system agents, and synthetic antibacterial agents for use in pharmaceuticals and stockbreeding. This division serves customers in the animal health sector by providing essential medical compounds for livestock and other animals. The Supplementary Feed segment complements the core operations by manufacturing and selling functional supplementary feeds and other related products. This segment targets the stockbreeding and fisheries industries, offering nutritional solutions to enhance animal health and productivity. By combining these two segments, ADBiotech Co., Ltd. delivers a comprehensive range of chemical and feed-based solutions to its clients in Chuncheon, Gangwon-Do. ADBiotech Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about ADBiotech Co stock

Capital Intensity Ratio of ADBiotech Co is 375.34 % in 2025.

Capital Intensity Ratio of ADBiotech Co changed from 207.20 % to 375.34 %, representing a 81.15% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Capital Intensity Ratio ADBiotech Co since 2006 – with annual values, charts, and detailed analysis.

Capital intensity measures the amount of assets needed to generate each unit of revenue. Lower ratios indicate asset-light business models.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Capital Intensity Ratio's ADBiotech Co with sector peers and the industry average to assess whether it is attractive.

To evaluate Capital Intensity Ratio's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Capital Intensity Ratio.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Profitability — ADBiotech Co

All Key Metrics — ADBiotech Co